Frontiers in Immunology

Frontiers in Immunology is a leading open-access journal published by Frontiers Media SA, dedicated to advancing the understanding of the immune system in health and disease. With ISSN 1664-3224 and an Impact Factor of 7.0000 (2026), the journal holds a prestigious Q1 ranking in the JCR quartile, underscoring its significant influence and high citation impact within the immunology field. The journal’s scope encompasses a broad spectrum of immunological research, including innate and adaptive immunity, inflammation, autoimmunity, tumor immunology, transplantation, immunodeficiency, and immunotherapies. It publishes a diverse array of article types, including original research articles, comprehensive reviews, mini-reviews, perspectives, hypotheses, and method papers, ensuring a comprehensive platform for disseminating novel findings and theoretical advancements. The target audience includes immunologists, clinicians, molecular biologists, pharmacologists, and biomedical researchers seeking cutting-edge insights into immune mechanisms and therapeutic applications. A standout feature of Frontiers in Immunology is its rigorous, collaborative peer-review process, which emphasizes transparency and efficiency, coupled with its open-access model that ensures all published content is freely accessible to the global scientific community. This accessibility, combined with the journal’s high impact factor and Q1 status, solidifies its reputation as a premier venue for high-quality immunological research. By fostering interdisciplinary dialogue and rapid dissemination of knowledge, Frontiers in Immunology continues to shape the landscape of immunological science, making it an essential resource for both established experts and emerging investigators.